1. Home
  2. PIRS vs MSS Comparison

PIRS vs MSS Comparison

Compare PIRS & MSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PIRS
  • MSS
  • Stock Information
  • Founded
  • PIRS 2001
  • MSS 2019
  • Country
  • PIRS United States
  • MSS United States
  • Employees
  • PIRS N/A
  • MSS N/A
  • Industry
  • PIRS Biotechnology: Pharmaceutical Preparations
  • MSS
  • Sector
  • PIRS Health Care
  • MSS
  • Exchange
  • PIRS Nasdaq
  • MSS Nasdaq
  • Market Cap
  • PIRS 22.4M
  • MSS 19.4M
  • IPO Year
  • PIRS N/A
  • MSS 2023
  • Fundamental
  • Price
  • PIRS $15.93
  • MSS $0.98
  • Analyst Decision
  • PIRS
  • MSS
  • Analyst Count
  • PIRS 0
  • MSS 0
  • Target Price
  • PIRS N/A
  • MSS N/A
  • AVG Volume (30 Days)
  • PIRS 37.6K
  • MSS 29.1K
  • Earning Date
  • PIRS 11-13-2024
  • MSS 12-16-2024
  • Dividend Yield
  • PIRS N/A
  • MSS N/A
  • EPS Growth
  • PIRS N/A
  • MSS N/A
  • EPS
  • PIRS N/A
  • MSS N/A
  • Revenue
  • PIRS $1,352,000.00
  • MSS $73,940,226.00
  • Revenue This Year
  • PIRS N/A
  • MSS N/A
  • Revenue Next Year
  • PIRS N/A
  • MSS N/A
  • P/E Ratio
  • PIRS N/A
  • MSS N/A
  • Revenue Growth
  • PIRS N/A
  • MSS 28.05
  • 52 Week Low
  • PIRS $6.20
  • MSS $0.60
  • 52 Week High
  • PIRS $22.32
  • MSS $22.97
  • Technical
  • Relative Strength Index (RSI)
  • PIRS 43.29
  • MSS 46.91
  • Support Level
  • PIRS $15.15
  • MSS $0.94
  • Resistance Level
  • PIRS $16.97
  • MSS $1.14
  • Average True Range (ATR)
  • PIRS 0.72
  • MSS 0.07
  • MACD
  • PIRS -0.08
  • MSS 0.00
  • Stochastic Oscillator
  • PIRS 30.75
  • MSS 37.83

About PIRS Pieris Pharmaceuticals Inc.

Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of the Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store, and transport a wide spectrum of molecules. The Company's clinical pipeline consists of immuno-oncology, or IO, bispecifics in partnership with collaborators, including S095012 (also referred to as PRS-344) targeting PD-L1 and 4-1BB, SGN-BB228 (also referred to as PRS-346) targeting CD228 and 4-1BB, and BOS-342 (also referred to as PRS-342) targeting GPC3 and 4-1BB. Geographically, all the operations of the firm function through the region of the United States.

About MSS Maison Solutions Inc.

Maison Solutions Inc is a fast-growing, specialty grocery retailer offering traditional Asian food and merchandise to modern U.S. consumers, particularly members of Asian-American communities. It is committed to providing Asian fresh produce, meat, seafood, and other daily necessities in a manner that caters to traditional Asian-American family values and cultural norms, while also accounting for the new and faster-paced lifestyle of younger generations and the diverse communities in which it operates. The company's merchandise includes fresh and, meats, seafood, and other groceries that are not found in mainstream supermarkets, including a variety of Asian vegetables and fruits such as broccoli, bitter melon, winter gourd, Shanghai baby bok choy, longan, and lychee.

Share on Social Networks: